TRI

14.3%

2.4¢ trivarx ltd

The technology is not there to diagnose mental health...

First 126 Last

Share
Profile

Follow
phamp

92 Posts.

25/04/18

21:27

Post #: 32680183
Share

Originally posted by rgc68 ↑

I don't get here very often....

The issue with validation is critical. Without it there will be NO uptake by the medical profession. Without it I'd be surprised if there was any significant corporate uptake. Why? Because it's one thing for a private individual to use an App and self diagnose this or that, but if your employer offers this to you then the employer owns the results. By owns, I mean the employer is now responsible for addressing the issue that has been exposed by the App. It's one thing if the test is high specificity, but if it turns up a whole lot of false positives then that's going to create a lot of problems. Probably false negatives are also going create problems too (but you told me I was fine and here I am having had a mental breakdown - I think I am going to sue you). Potentially very expensive problems. I can't see how any company with good governance could possibly take on such a device.

Unfortunately a lot of people here have conflated the fact that mental health is a big unmet need with the presumption that a device that is said to 'diagnose' it with modern technology must be a surefire winner. The step missing is that the device has not been proven to do what it is said to do to the level required for safe use. Maybe clinical trials may give such data, but you'll be waiting a while for those.

Expand

The technology is not there to diagnose mental health conditions. It is an objective testing used to assist with the diagnosis of these conditions.

MEB Price at posting: 15.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

CCO

The Calmer Co’s Anthony Noble reflects on record breaking FY24

HLX

Helix investor makes partial takeover bid, proposing board changes

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

There are more pages in this discussion • 7 more messages in this thread...

First 126 Last

Add TRI (ASX) to my watchlist

(20min delay)
Last 2.4¢		Change 0.003(14.3%)		Mkt cap ! $10.96M

Open	High	Low	Value	Volume
2.2¢	2.4¢	2.2¢	$1.931K	86.66K

Buyers (Bids)

No.	Vol.	Price($)
2	368464	2.1¢

Sellers (Offers)

Price($)	Vol.	No.
2.4¢	288024	3

View Market Depth

No.	Vol.	Price($)
2	368464	0.021
2	300000	0.020
2	1000000	0.019
3	1750000	0.018
5	1076000	0.017

Price($)	Vol.	No.
0.024	288024	3
0.026	455040	3
0.027	500000	1
0.028	160000	1
0.030	236823	2

Last trade - 12.09pm 30/08/2024 (20 minute delay)

TRI (ASX) Chart

The technology is not there to diagnose mental health...

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Helix investor makes partial takeover bid, proposing board changes

Lendlease sells off US east coast construction operations in latest global divestment push

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

The technology is not there to diagnose mental health...

Top Stories

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Helix investor makes partial takeover bid, proposing board changes

Lendlease sells off US east coast construction operations in latest global divestment push

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News